Lucira Health, Inc. Balance Sheet

Ask AI

Financial Statements

In millions of USD, except per-share amounts

	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021	Q2 FY2021 As of Jun 30, 2021	Q1 FY2021 As of Mar 31, 2021
Assets
Current assets:
Cash and cash equivalents
Accounts receivable, net
Inventory
Grant income receivable
Other receivable
Prepaid expenses
Other current assets
Total current assets
Property and equipment, net
Operating lease right-of-use assets
Restricted cash equivalents
Other assets
Total assets
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable
Accrued liabilities
Operating lease liabilities, current
Customer deposits
Total current liabilities
Term loan payable, net
Operating lease liabilities, net of current portion
Total liabilities
Stockholders’ equity:
Common stock, $0.001 par value; 200,000,000 shares authorized as of September 30, 2022 and December 31, 2021; 40,448,703 and 39,663,645 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively
Additional paid-in capital
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments